Featured Research

from universities, journals, and other organizations

Novel Prostate Cancer Marker May Lead To Earlier Diagnosis And Fewer Repeat Bioposies

Date:
March 12, 2004
Source:
University Of Pittsburgh Medical Center
Summary:
Findings published in this month's issue of the Journal of Urology indicate that prostate cancer could be detected as many as five years earlier than it is currently being diagnosed by testing for a protein in tissue that indicates the presence of early disease.

PITTSBURGH, March 11 – Findings published in this month's issue of the Journal of Urology indicate that prostate cancer could be detected as many as five years earlier than it is currently being diagnosed by testing for a protein in tissue that indicates the presence of early disease. The researchers suggest that testing for the protein, EPCA, could serve as an adjunct to the current diagnostic approach to patients with elevated levels of prostate-specific antigen, or PSA, who undergo repeat needle biopsies. PSA, a substance in the blood released by the prostate gland, is commonly used to check for signs of prostate cancer and other prostate problems.

"One of the problems with testing for levels of PSA as an indicator of prostate cancer is that PSA levels often fluctuate up and down, making it difficult to know for certain whether a man has prostate cancer without performing multiple biopsies over time," said Robert Getzenberg, Ph.D., senior author and professor of urology, pathology and pharmacology at the University of Pittsburgh School of Medicine. "By testing for EPCA in men with high levels of PSA, we may be able to detect the presence of prostate cancer earlier, before it is discoverable by biopsy, saving patients the fear and stress of repeat procedures and enabling us to treat the disease sooner."

Dr. Getzenberg explained that EPCA is a marker protein that indicates the earliest changes that occur in cells during the development of cancer.

In the study, Dr. Getzenberg, also co-director of the Prostate and Urologic Cancer Program at the University of Pittsburgh Cancer Institute, and colleagues developed antibodies against EPCA to detect its presence in tissue. They compared 27 non-diseased control tissue samples to 29 tissue samples from patients with prostate cancer who had initial negative biopsies. They found that the samples from the negative biopsies of those patients who were eventually diagnosed with prostate cancer expressed EPCA and that EPCA was not expressed in tissue samples from individuals without disease. They also found that EPCA was not only expressed in the tumor, but throughout the prostate in men with prostate cancer indicating its usefulness as a prognostic marker for prostate cancer.

A multi-center study is currently underway to further assess the usefulness of EPCA and its possible use as a biomarker for prostate cancer.

Prostate cancer exceeds lung cancer as the most commonly diagnosed cancer among men in the United States with 220,900 new cases and 28,900 deaths in 2003. More than 70 percent of all prostate cancer cases are diagnosed in men over age 65.

The study was supported by a grant from Tessera Inc., Seattle, Wash. Co-authors include Rajiv Dhir, Ph.D., Barbara N. Vietmeier, Julie Arlotti, Ph.D., Marie Acquafondata, Ph.D., and Douglas Landsittel, Ph.D., of the University of Pittsburgh School of Medicine and Robert Materson, Ph.D., of Tessera Inc.


Story Source:

The above story is based on materials provided by University Of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pittsburgh Medical Center. "Novel Prostate Cancer Marker May Lead To Earlier Diagnosis And Fewer Repeat Bioposies." ScienceDaily. ScienceDaily, 12 March 2004. <www.sciencedaily.com/releases/2004/03/040311071013.htm>.
University Of Pittsburgh Medical Center. (2004, March 12). Novel Prostate Cancer Marker May Lead To Earlier Diagnosis And Fewer Repeat Bioposies. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2004/03/040311071013.htm
University Of Pittsburgh Medical Center. "Novel Prostate Cancer Marker May Lead To Earlier Diagnosis And Fewer Repeat Bioposies." ScienceDaily. www.sciencedaily.com/releases/2004/03/040311071013.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
U.S. Food Makers Surpass Calorie-Cutting Pledge

U.S. Food Makers Surpass Calorie-Cutting Pledge

Newsy (Sep. 18, 2014) Sixteen large food and beverage companies in the United States that committed to cut calories in their products far surpassed their target. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins